Friday, July 30, 2021 11:50:09 AM
This could be very good news if FluroTech gets the ball rolling.
MarketSmart is out of the picture, and FluroTech is no longer listed as one of their clients. This is good as press releases and Twitter posts have done nothing for the share price. And looking at MarketSmart's client list reveals a promotional company that can't promote!
PCR tests, long hailed as the "gold standard" in detecting SARS-Cov-2 cases, will be dropped by the U.S. Centers for Disease Control and Prevention at the beginning of next year.
Polymerase chain reaction tests have been a mainstay of the U.S. and global response to COVID-19 since early in 2020, but health officials have warned the diagnostic tool poses a risk of false-positive results.
The test works by amplifying a biological sample through successive cycles until a virus — if it's present in the assay — can be detected by the testing machine.
The CDC announced this month that it would be withdrawing its request to the U.S. Food and Drug Administration for the emergency use authorization of the test. The agency urged laboratories to "begin their transition to another FDA-authorized COVID-19 test."
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM